Ulcerative proctitis (UP) is a common condition in adult patients and can be very dif-ficult to treat. This review considers critically the definition of this entity, its epidemi-ology and course, and the modes of therapy currently available. Therapies currently in development are considered as well.
KeywordsUlcerative ProctitisEpidemiologyTherapy
Silverberg, M.S., Satsangi, J., Ahmad, T., et al. (2005) Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Canadian Journal of Gastroenterology, 19, 5-36. http://dx.doi.org/10.1155/2005/269076
Langevin, S., Menard, D.B., Haddad, H., et al. (1992) Idiopathic Ulcerative Proctitis May Be the Initial Manifestation of Crohn’s Disease. Journal of Clinical Gastroenterology, 15, 199-204. http://dx.doi.org/10.1097/00004836-199210000-00005
Whitlow, C.B. (2004) Ulcerative Proctitis. Clinics in Colon and Rectal Surgery, 17, 21-27. http://dx.doi.org/10.1055/s-2004-823067
Bernstein, C. (2010) New Insights into IBD Epidemiology: Are There Any Lessons for Treatment? Digital Distribution, 26, 406-410. http://dx.doi.org/10.1159/000320394
Loftus, C.G., Loftus Jr., E.V., Harmsen, W.S., et al. (2007) Update on the Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota, 1940-2000. Inflammatory Bowel Diseases, 13, 254-261. http://dx.doi.org/10.1002/ibd.20029
Loftus Jr., E.V., Silverstein, M.D., Sandborn, W.J., Tremaine, W.J., Harmsen, W.S. and Zinsmeister, A.R. (2000) Ulcerative Colitis in Olmsted County, Minnesota, 1940-1993: Incidence, Prevalence, and Survival. Gut, 46, 336-343. http://dx.doi.org/10.1136/gut.46.3.336
Solberg, I.C., Lygren, I., Jahnsen, J., et al. (2009) Clinical Course during the First 10 Years of Ulcerative Colitis: Results from a Population-Based Inception Cohort (IBSEN Study). Scandinavian Journal of Gastroenterology, 44, 431-440. http://dx.doi.org/10.1080/00365520802600961
Jess, T., Riss, L., Vind, I., et al. (2007) Changes in Clinical Characteristics, Course, and Prognosis of Inflammatory Bowel Disease during the Last 5 Decades: A Population-Based Study from Copenhagen, Denmark. Inflammatory Bowel Diseases, 13, 481-489. http://dx.doi.org/10.1002/ibd.20036
Burisch, J., Pedersen, N., Cukovic-Cavka, S., et al. (2014) East-West Gradient in the Incidence of Inflammatory Bowel Disease in Europe: The ECCO-EpiCom Inception Cohort. Gut, 63, 588-597. http://dx.doi.org/10.1136/gutjnl-2013-304636
Safroneeva, E., Vavricka, S., Fournier, N., et al. (2015) Systemic Analysis of Factors Associated with Progression and Regression of Ulcerative Colitis in 918 Patients. Alimentary Pharmacology & Therapeutics, 42, 540-548. http://dx.doi.org/10.1111/apt.13307
Meucci, G., Vecchi, M., Astegiano, M., et al. (2000) The Natural History of Ulcerative Proctitis. American Journal of Gastroenterology, 95, 469-473. http://dx.doi.org/10.1111/j.1572-0241.2000.t01-1-01770.x
Regueiro, M., Loftus, E.V., Steinhart, A.H. and Cohen, R.D. (2006) Clinical Guidelines for the Medical Management of Left-Sided Ulcerative Colitis and Ulcerative Proctitis; Summary Statement. Inflammatory Bowel Diseases, 12, 972-978. http://dx.doi.org/10.1097/01.mib.0000231496.92013.85
Meier, J. and Sturm, A. (2011) Current Treatment of Ulcerative Colitis. World Journal of Gastroenterology, 21, 3204-3212.
Ford, A.C., Achkar, J.P., Khan, K.J., et al. (2011) Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis. American Journal of Gastroenterology, 106, 601-616. http://dx.doi.org/10.1038/ajg.2011.67
Kamm, M.A., Sandborn, W.J., Gassull, M., et al. (2007) Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative Colitis. Gastroenterology, 132, 66-75. http://dx.doi.org/10.1053/j.gastro.2006.10.011
Burger, D. and Travis, S. (2011) Conventional Medical Management of Inflammatory Bowel Disease. Gastroenterology, 140, 1827-1837. http://dx.doi.org/10.1053/j.gastro.2011.02.045
Marshall, J.K., Thabane, M., Steinhart, A.H., Newman, J.R., Anand, A. and Irvine, E.J. (2012) Rectal 5-Aminosalicylic Acid for Maintenance of Remission in Ulcerative Colitis. Cochrane Database of Systematic Reviews, 11, Article ID: CD004118. http://dx.doi.org/10.1002/14651858.cd004118.pub2
Lucidarme, D., Marteau, P., Foucault, M., Vautrin, B. and Filoche, B. (1997) Efficacy and Tolerance of Mesalazine Suppositories vs. Hydrocortisone Foam in Proctitis. Alimentary Pharmacology & Therapeutics, 11, 335-340. http://dx.doi.org/10.1046/j.1365-2036.1997.126297000.x
Oren, R., Arber, N., Odes, S., et al. (1996) Methotrexate in Chronic Ulcerative Colitis: A Double-Blind, Randomized, Israeli Multicenter Trial. Gastroenterology, 110, 1416-1421. http://dx.doi.org/10.1053/gast.1996.v110.pm8613046
Ford, A.C., Sandborn, W.J., Khan, K.J., et al. (2011) Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. American Journal of Gastroenterology, 106, 644-650. http://dx.doi.org/10.1038/ajg.2011.73
Bouguen, G., Roblin, X., Bourreille, A., et al. (2010) Infliximab for Refractory Ulcerative Proctitis. Alimentary Pharmacology & Therapeutics, 31, 1178-1185. http://dx.doi.org/10.1111/j.1365-2036.2010.04293.x
Molnar, T., Faskask, K., Nagy, F., Németh, I. and Wittmann, T. (2009) Topically Administered Infliximab Can Work in Ulcerative Proctitis Despite the Ineffectiveness of Intravenous Induction Therapy. American Journal of Gastroenterology, 104, 1857-1858. http://dx.doi.org/10.1038/ajg.2009.147
Gies, N., Kroeker, K.I., Wong, K. and Fedorak, R.N. (2010) Treatment of Ulcerative Colitis with Adalimumab or Infliximab: Long-Term Follow-Up of a Single-Centre Cohort. Alimentary Pharmacology & Therapeutics, 32, 522-528. http://dx.doi.org/10.1111/j.1365-2036.2010.04380.x
Thorland, K., Druyts, E., Toor, K. and Mills, E.J. (2015) Comparative Efficacy of Golimumab, Infliximab, and Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Network Meta-Analysis Accounting for Differences in Trial Designs. Expert Review of Gastroenterology & Hepatology, 9, 693-700. http://dx.doi.org/10.1586/17474124.2015.1024657
Odes, S. and Greenberg, D. (2014) A Medicoeconomic Review of Early Intervention with Biological Agents in the Treatment of Inflammatory Bowel Disease. ClinicoEconomics & Outcomes Research, 6, 431-443. http://dx.doi.org/10.2147/CEOR.S39212
Sandborn, W.J., Bosworth, B., Zakko, S., et al. (2015) Budesonide Foam Induces Remission in Patients with Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis. Gastroenterology, 148, 740-750. http://dx.doi.org/10.1053/j.gastro.2015.01.037
Navas-Lopez, V.M., Blasco-Alonso, J., Giron Fernandez-Crehuet, F., et al. (2014) Successful Treatment for Ulcerative Proctitis with Rectal Tacrolimus in an 8-Year-Old Girl with Intolerance to Mesalamine. Clinical Journal of Gastroenterology, 7, 320-323. http://dx.doi.org/10.1007/s12328-014-0506-2
Guslandi, M., Petrone, M.C. and Testoni, P.A. (2006) Rifaximin for Active Ulcerative Colitis. Inflammatory Bowel Diseases, 12, 335. http://dx.doi.org/10.1097/01.MIB.0000215092.85116.6c
Bolin, T.D., Wong, S., Crouch, R., et al. (2009) Appendectomy as a Therapy for Ulcerative Proctitis. American Journal of Gastroenterology, 104, 2476-2482. http://dx.doi.org/10.1038/ajg.2009.388
Bageacu, S., Coatmeur, O., Lemaitre, J.P., et al. (2011) Appendectomy as a Potential Therapy for Refractory Ulcerative Proctitis. Alimentary Pharmacology & Therapeutics, 34, 252-253. http://dx.doi.org/10.1111/j.1365-2036.2011.04705.x
Andersson, R.E., Olaison, G., Tysk, C., et al. (2001) Appendectomy and Protection against Ulcerative Colitis. New England Journal of Medicine, 344, 808-814. http://dx.doi.org/10.1056/NEJM200103153441104
Peyrin-Biroulet, L., Bouhnik, Y., Roblin, X., et al. (2016) French National Consensus Clinical Guidelines for the Management of Ulcerative Colitis. Digestive and Liver Disease, 48, 726-733. http://dx.doi.org/10.1016/j.dld.2016.03.029
Feldman, M., Friedman, L.S. and Brandt, L.J. (2010) Gastrointestinal and Liver Disease. 9th Edition, Elsevier, Philadelphia, 1960-1971.